Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.

Source:http://linkedlifedata.com/resource/pubmed/id/18215773

Download in:

View as

General Info

PMID
18215773